Advertisement

Topics

Sun Primes Late-Stage Psoriasis Asset With Samsung Manufacturing Deal

12:38 EDT 4 Jul 2017 | SCRIP

Sun Pharma has firmed up a manufacturing pact for tildrakizumab with Samsung BioLogics, securing supplies of its late-stage psoriasis asset...

      

Related Stories

 

Original Article: Sun Primes Late-Stage Psoriasis Asset With Samsung Manufacturing Deal

NEXT ARTICLE

More From BioPortfolio on "Sun Primes Late-Stage Psoriasis Asset With Samsung Manufacturing Deal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...